Table 1 Characteristics of included patients/implants
Table 1 Characteristics of included patients/implants
author: Diederik F M Hentenaar, Yvonne C M De Waal, Hans Strooker, Henny J A Meijer, Arie-Jan Van Winkelhoff, Gerry M Raghoebar | publisher: drg. Andreas Tjandra, Sp. Perio, FISID
Table 1 Characteristics of included patients/implants
| Characteristics | Control | Test |
|---|---|---|
| Number of patients | 14 | 14 |
| Age (years; mean [SD]) | 57.0 (13.7) | 60.9 (7.2) |
| Gender; M (male), F (female) | M5, F9 | M7, F7 |
| Smoking; n subjects (%) | 1 (7%) | 3 (21%) |
| History of periodontitis; n subjects (%) | 4 (29%) | 5 (36%) |
| Dental status; n subjects (%) | ||
| - Partially edentulous | 13 (93%) | 12 (86%) |
| - Fully edentulous | 1 (7%) | 2 (14%) |
| Total number of implants (range) | 68 (1–9) | 60 (1–10) |
| Number of implants with peri-implantitis (range) | 22 (1–4) | 31 (1–5) |
| Mean bone loss at baseline in mm (SD) | 2.73 (1.49) | 3.58 (1.57) |
Serial posts:
- Implant decontamination with phosphoric acid
- Background : Implant decontamination with phosphoric acid
- Methods : Implant decontamination with phosphoric acid
- Interventions : Implant decontamination with phosphoric acid
- Outcomes : Implant decontamination with phosphoric acid
- Randomization : Implant decontamination with phosphoric acid
- Statistical analysis : Implant decontamination with phosphoric acid
- Results : Implant decontamination with phosphoric acid (1)
- Results : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (1)
- Discussion : Implant decontamination with phosphoric acid (2)
- Discussion : Implant decontamination with phosphoric acid (3)
- References : Implant decontamination with phosphoric acid
- Table 1 Characteristics of included patients/implants
- Table 2 Log-transformed mean bacterial anaerobic counts
- Table 3 Log-transformed mean bacterial anaerobic counts
- Table 4 Descriptive statistics of clinical parameters
- Table 5 Average differences in BoP, SoP, and PPD between the control and test group at 3-month follow-up
- Figure 1. Flow diagram